Major cardiovascular events (MACE), spontaneous intracerebral hemorrhage research hub

Colchicine for the Reduction of Dependency and Vascular Events after an Acute Intracerebral Hemorrhage (CoVasc-ICH2)

This trial looks at whether an anti-inflammatory medicine called colchicine can help people recover after bleeding in the brain. Researchers want to find out if taking a daily tablet reduces the chances of future strokes, heart attacks, and long-term disability compared to taking a dummy tablet.